Formulation Characterization and Optimization of Photosensitive Liposomes for Targeted Drug Delivery Using UV Light Activation
DOI:
https://doi.org/10.52783/jns.v14.2255Keywords:
NSAIDs, Reverse Phase Evaporation, Liposomes, UV light, Photosensitive liposomesAbstract
This study explores the formulation, characterization, and optimization of photosensitive liposomes for targeted drug delivery activated by UV light. Liposomes, self-forming spherical vesicles made of phospholipids, are effective carriers for drugs, offering the advantage of localized delivery and reduced systemic distribution. The research focuses on incorporating non-steroidal anti-inflammatory drugs (NSAIDs), specifically Ketoprofen (KP), into liposomes using the reverse phase evaporation (REV) method, achieving high encapsulation efficiency. Optimization studies revealed that increasing cholesterol content in the liposome formulation resulted in larger vesicle sizes but decreased drug entrapment efficiency. Morphological analysis confirmed the presence of both unilamellar and multilamellar vesicles. The physicochemical properties, including vesicle size and drug entrapment efficiency, were significantly influenced by the lipid-to-drug ratio and cholesterol content. A key aspect of this study was the use of UV light to trigger the release of encapsulated KP from the liposomes. UV-induced destabilization of the lipid bilayers facilitated controlled drug release, demonstrating the potential of this method for precise spatial and temporal delivery. The findings suggest that photosensitive liposomes, optimized for drug encapsulation and size, are promising vehicles for targeted drug delivery systems, offering controlled release upon UV light activation. This approach highlights the potential for enhanced therapeutic efficacy and reduced side effects, paving the way for future research and clinical applications.
Downloads
Metrics
References
Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of molecular biology. 1965 Aug 1;13(1):238-IN27.
Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nano-enabled medical applications. 2020 Nov 23:61-91.
Andresen TL, Jensen SS, Jørgensen K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Progress in lipid research. 2005 Jan 1;44(1):68-97.
Guo X, Szoka FC. Chemical approaches to triggerable lipid vesicles for drug and gene delivery. Accounts of chemical research. 2003 May 20;36(5):335-41.
Çirli ÖÖ, Hasırcı V. UV-induced drug release from photoactive REV sensitized by suprofen. Journal of controlled release. 2004 Apr 16;96(1):85-96.
Costanzo LL, Guidi GD, Condorelli G, Cambria A, Fama M. Molecular mechanism of drug photosensitization–II. Photohemolysis sensitized by ketoprofen. Photochemistry and photobiology. 1989 Sep;50(3):359-65.
Szoka Jr F, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proceedings of the national academy of sciences. 1978 Sep;75(9):4194-8.
Glavas-Dodov M, Fredro-Kumbaradzi E, Goracinova K, Calis S, Simonoska M, Hincal AA. 5-Fluorouracil in topical liposome gels for anticancer treatment--formulation and evaluation. Acta pharmaceutica (Zagreb, Croatia). 2003 Dec 1;53(4):241-50.
Wagner A, Vorauer-Uhl K. Liposome technology for industrial purposes. Journal of drug delivery. 2011;2011(1):591325.
Perkins WR, Minchey SR, Ahl PL, Janoff AS. The determination of liposome captured volume. Chemistry and physics of lipids. 1993 Sep 1;64(1-3):197-217.
Lee BS, Choi YG, Son WC, Jung KM, Kim JJ, Kim BH. Ketoprofen: experimental overview of dermal toxicity. Archives of toxicology. 2007 Oct;81(10):743-8.
Mitkari BV, Korde SA, Mahadik KR, Kokare CR. Formulation and evaluation of topical liposomal gel for fluconazole. Indian J Pharm Educ Res. 2010 Oct 1;44(4):324-33.
Shivhare UD, Ambulkar DU, Mathur VB, Bhusari KP, Godbole MD. Formulation and evaluation of pentoxifylline liposome formulation. Digest journal of nanomaterials and biostructures. 2009 Dec 1;4(4):857-62.
Satyavathi K, Bhojaraju P, Srikranthi M, Sudhakar P. Formulation and in-vitro evaluation of liposomal drug delivery system of cabazitaxel. J Pharm Drug Deliv Res. 2015;4:2.
Kulkarni SB, Betageri GV, Singh M. Factors affecting microencapsulation of drugs in liposomes. Journal of microencapsulation. 1995 Jan 1;12(3):229-46.
Ramana LN, Sethuraman S, Ranga U, Krishnan UM. Development of a liposomal nanodelivery system for nevirapine. Journal of biomedical science. 2010 Dec;17:1-9.
Semple SC, Chonn A, Cullis PR. Influence of cholesterol on the association of plasma proteins with liposomes. Biochemistry. 1996 Feb 27;35(8):2521-5.
Lagerquist C, Beigi F, Karlén A, Lennernäs H, Lundahl P. Effects of cholesterol and model transmembrane proteins on drug partitioning into lipid bilayers as analysed by immobilized‐liposome chromatography. Journal of Pharmacy and Pharmacology. 2001 Nov;53(11):1477-87.
Nallamothu R, Wood GC, Kiani MF, Moore BM, Horton FP, Thoma LA. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies. PDA Journal of Pharmaceutical Science and Technology. 2006 May 1;60(3):144.
Bhatia A, Kumar R, Katare OP. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J Pharm Pharm Sci. 2004 Jul 16;7(2):252-9.
Mayer LD, Tai LC, Ko DS, Masin D, Ginsberg RS, Cullis PR, Bally MB. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer research. 1989 Nov 1;49(21):5922-30.
Kan P, Tsao CW, Wang AJ, Su WC, Liang HF. A liposomal formulation able to incorporate a high content of Paclitaxel and exert promising anticancer effect. Journal of drug delivery. 2011;2011(1):629234.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.